Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Powder Formulation of Clopidogrel (Generic Plavix(R)) to Address Gastric Bleeding Risks

New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel. Clopidogrel, currently sold under the brand name Plavix®, ...

Aspire files patent application for clopidogrel sublingual powder formulation

Aspire Biopharma (ASBP) announced the filing of a new provisional patent application with the United States Patent and ...
MM&M

Generic Plavix imminent, says Medco Health

Medco Health Solutions says it expects a generic version of the blockbuster Bristol-Myers Squibb and Sanofi-Aventis blood thinner Plavix to become available in the United States this year. The ...
Reuters

Sanofi, BMS hit by generic Plavix threat in Europe

LONDON (Reuters) - Sanofi-Aventis and Bristol-Myers Squibb , which are just recovering from defeating generic competition to their top-selling Plavix drug in the United States, now face a similar ...
Medscape

New indication for clopidogrel in acute MI, while generic showdown continues

News of the expanded indication comes during a showdown between the marketer/manufacturer of the drug, Bristol-Myers Squibb (BMS)/Sanofi-Aventis, and Canadian drug company Apotex, which started ...
TheStreet.com

Plavix Facing Generic Challenge

The Food and Drug Administration on Tuesday said a Canadian company could sell a generic version of the anticoagulant Plavix, the biggest-selling drug for , the developer of Plavix and the marketing ...
Los Angeles Times

Generic Form of Drug Plavix Enters Market

Sanofi-Aventis and Bristol-Myers Squibb Co. are facing generic competition in the U.S. for their top-selling Plavix blood-thinning pill five years earlier than planned. Apotex Inc., a closely held ...
Reuters

Sanofi to launch own generic version of Plavix

PARIS/LONDON (Reuters) - French drugmaker Sanofi-Aventis is preparing to sell its own generic version of the blockbuster heart medicine Plavix in France, a company spokesman said on Monday. Plavix, ...
MM&M

Plavix probe widens; BMS earnings take a beating

Bristol-Myers Squibb said generic competition on its biggest drug, Plavix, hamstrung third-quarter earnings, while a federal probe expanded to determine whether an ill-fated deal to protect the Plavix ...
PharmaTimes

Deal could keep Plavix from generic competition

Sanofi-Aventis and Bristol-Myers Squibb have cut a deal with a generic company that could keep a copycat version of their multibillion drug Plavix off the market until 2011. Sanofi-Aventis and Bristol ...
Healio

High clopidogrel dose not beneficial after MINOCA

Please provide your email address to receive an email when new articles are posted on . Patients with MI with nonobstructive coronary arteries, or MINOCA, have fewer recurrent events than those with ...

Aspire Biopharma Holdings, Inc.: Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Powder Formulation of Clopidogrel to Address Gastric ...

New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.Clopidogrel, currently sold under the brand name Plavix, was ...